Iradimed Corporation will participate in the Needham Virtual Healthcare Conference, hosting investor meetings from April 13-16, 2026.
Quiver AI Summary
Iradimed Corporation announced its participation in the 25th Annual Needham Virtual Healthcare Conference, taking place from April 13-16, 2026, where CFO Jack Glenn will engage in one-on-one investor meetings. The company specializes in developing MRI-compatible medical devices, including its patented MRidium® IV infusion pump system, which is designed to operate safely during MRI procedures without interference from magnetic fields. This system, along with the Iradimed 3880 patient vital signs monitoring system, enhances patient safety and care, particularly for critically ill patients and children requiring sedation during scans. The 3880 system features advanced monitoring capabilities and is designed to function reliably within high magnetic fields, ensuring continuous observation of vital signs during MRIs. For further details, visit the company's website.
Potential Positives
- Iradimed Corporation's participation in the 25th Annual Needham Virtual Healthcare Conference enhances visibility and engagement with investors, potentially attracting new investment opportunities.
- The company’s unique position as the sole provider of a non-magnetic IV infusion pump specifically designed for MRI procedures showcases its innovative capabilities and reinforces its market leadership in MRI-compatible medical devices.
- The introduction of the MRidium® MRI-compatible IV infusion pump and the 3880 patient vital signs monitoring system highlights the company’s commitment to improving patient safety and care during critical MRI procedures.
Potential Negatives
- Participation in a virtual conference may indicate a lack of in-person engagement with investors, which could be perceived as a less proactive approach to investor relations.
FAQ
What is the 25th Annual Needham Virtual Healthcare Conference?
The 25th Annual Needham Virtual Healthcare Conference is an event where healthcare companies connect with investors and stakeholders.
Who is representing Iradimed Corporation at the conference?
Jack Glenn, the Chief Financial Officer of Iradimed Corporation, will represent the company at the conference.
When will the Needham Healthcare Conference take place?
The conference is scheduled to occur from April 13-16, 2026.
What products does Iradimed Corporation specialize in?
Iradimed Corporation specializes in developing MRI-compatible medical devices, including IV infusion pumps and patient vital signs monitoring systems.
How does Iradimed's technology benefit critically ill patients?
Iradimed's technology allows for safe and accurate medication delivery and monitoring during MRI scans, crucial for critically ill patients.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$IRMD Insider Trading Activity
$IRMD insiders have traded $IRMD stock on the open market 71 times in the past 6 months. Of those trades, 0 have been purchases and 71 have been sales.
Here’s a breakdown of recent trading of $IRMD stock by insiders over the last 6 months:
- ROGER E. SUSI (CEO, President, Chairman) has made 0 purchases and 60 sales selling 120,000 shares for an estimated $11,174,836.
- JOHN GLENN (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 25,651 shares for an estimated $2,359,503.
- JAMES B HAWKINS has made 0 purchases and 7 sales selling 6,000 shares for an estimated $554,554.
- MONTY K ALLEN sold 1,000 shares for an estimated $100,256
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IRMD Revenue
$IRMD had revenues of $22.7M in Q4 2025. This is an increase of 17.03% from the same period in the prior year.
You can track IRMD financials on Quiver Quantitative's IRMD stock page.
$IRMD Hedge Fund Activity
We have seen 111 institutional investors add shares of $IRMD stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NINE TEN CAPITAL MANAGEMENT LLC removed 342,907 shares (-44.5%) from their portfolio in Q4 2025, for an estimated $33,357,992
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC added 333,229 shares (+inf%) to their portfolio in Q4 2025, for an estimated $32,416,517
- MILLENNIUM MANAGEMENT LLC removed 94,982 shares (-96.7%) from their portfolio in Q4 2025, for an estimated $9,239,848
- INFORMED MOMENTUM CO LLC added 55,106 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,360,711
- FMR LLC added 46,274 shares (+226.2%) to their portfolio in Q4 2025, for an estimated $4,501,534
- SEI INVESTMENTS CO added 39,368 shares (+163.8%) to their portfolio in Q4 2025, for an estimated $3,829,719
- ALGERT GLOBAL LLC added 34,863 shares (+68.6%) to their portfolio in Q4 2025, for an estimated $3,391,472
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference.
Iradimed’s CFO, Jack Glenn, will host one-on-one meetings with investors at the 25th Annual Needham Virtual Healthcare Conference, which is scheduled to take place from April 13-16, 2026.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services.
We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system specifically designed for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can cause radio-frequency interference and are dangerous to operate in the presence of the powerful magnet used in an MRI system. Our patented MRidium® MRI-compatible IV infusion pump system has a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan.
Our 3880 MRI-compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The Iradimed 3880 system operates dependably in magnetic fields up to 30,000 gauss, allowing it to operate virtually anywhere in the MRI scanner room. The Iradimed 3880 has a compact, lightweight design, allowing it to travel with the patient from the critical care unit to the MRI and back, increasing patient safety through uninterrupted vital-signs monitoring and reducing the time critically ill patients are away from critical care units. The features of the Iradimed 3880 include wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and an optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The Iradimed 3880 MRI-compatible patient vital signs monitoring system has an easy-to-use design and enables effective communication of patient vital signs to clinicians.
For more information, please visit www.iradimed.com .
Media Contact:
Jack Glenn
Chief Financial Officer
IRADIMED CORPORATION
(407) 677-8022
[email protected]
